top of page


New in Print


  • Management of infectious disease syndromes in thoracic organ transplants and mechanical circulatory device recipients: a Delphi panel

Luong ML, Nakamachi Y, Silveira FP, Morrissey CO, Danziger-Isakov L, Verschuuren EAM, Wolfe CR, Hadjiliadis D, Chambers DC, Patel JK, Dellgren G, So M, Verleden GM, Blumberg EA, Vos R, Perch M, Holm AM, Mueller NJ, Chaparro C, Husain STranspl Infect Dis. 2024:e14251.

  • Assessing the quality of antimicrobial prescribing in solid organ transplant recipients: a new frontier in antimicrobial stewardship.

New icon.png

Kothari S, Ahmad SZ, Zhao MT, Teixeira-Barreira A, So M, Husain S. Antimicrobial Stewardship & Healthcare Epidemiology. 2024;4(1):e72.

  • Bring it on again: antimicrobial stewardship in transplant infectious diseases: updates and new challenges.

Tsai H, Bartash R, Burack D, Swaminathan N, So M.​ Antimicrob Steward Healthc Epidemiol. 2024;4(1):e3.

  • Pneumocystis jirovecii pneumonia in people living with HIV: a review.

McDonald EG, Afshar A, Assiri B, Boyles T, Hsu JM, Khuong N, Prosty C, So M, Sohani ZN, Butler-Laporte G, Lee TC. Clin Microbiol Rev. 2024;18:e0010122.


OPTIMIS PRO – A Novel Algorithm to Improve Perioperative Antibiotic Administration

McIntyre M, Vaisman A, Esmail T et al. The Society for Healthcare Epidemiology of America 2024.

Top Featured Poster Abstract 2024

Physiologically-Based Pharmacokinetic Modelling of Cefazolin Within The Cerebrospinal Fluid

Dubinsky S, McIntyre M, et al. European Congress of Clinical Microbiology & Infectious Diseases 2024.

Top Featured Poster Abstract 2024


  • Sarilumab for hospitalized patients with COVID-19

Wu PE, Hamandi B, Leung E, & Morris AMCMAJ.2023


  • Retrospective cohort analysis of outpatient antibiotic prescribing for community-acquired pneumonia in Canadian older adults.

Saatchi A, Reid JN, Shariff SZ, Povitz M, Silverman M, Patrick DM, Morris AM, et al. PLoS One. 2023;18(10):e0292899.

  • Identifying Patterns of Primary Care Antibiotic Prescribing for a Spinal Cord Injury (SCI) Cohort Using an Electronic Medical Records (EMR) Database

Senthinathan A, Penner M, Tu K, Morris AM, et al. Top Spinal Cord Inj Rehabil. 2023; 29(suppl):153–64. 

  • What is the place in therapy for nirmatrelvir/ritonavir?

Lee TC, Pogue JM, McCreary EK, Morris AM. BMJ Evid Based Med. 2023; 28(5):287-290.

  • Quality of antibiotic prescribing for pediatric community-acquired Pneumonia in outpatient care.

Saatchi A, Haverkate MR, Reid JN, Shariff SZ, Povitz M, Patrick DM, Silverman M, Morris AM, et al. BMC Pediatr. 2023;23(1):542.

  • The impact of the COVID-19 pandemic on blood culture practices and bloodstream infections.

Driedger M, Daneman N, Brown K, Gold WL, Jorgensen SC, Maxwell C, Schwartz KL, Morris AM, et al. Microbiol Spectr. 2023;11(6):e0263023.

  • Seeing the whole elephant: designing 'one health' governance to fight antimicrobial resistance.

Brunskill I, Somanader DS, Perrin M, et al. Clin Microbiol Infect.2023; 4:S1198-743X(23)00484-6.

  • Physician antimicrobial prescribing and patient outcomes on general medical wards: a multicentre retrospective cohort study

 McIntyre MT, Saha S, Morris AM, et al. CMAJ. 2023 Aug 21;195(32):E1065-E1074.

  • Examining antibiotic prescribing and urine culture testing for urinary tract infections (UTIs) in a primary care spinal cord injury (SCI) cohort.

Senthinathan A, Craven BC, Morris AM. et al. Spinal Cord. 2023[Epub]

  • Real-life implications of prevalence meta-analyses? Doi plots and prediction intervals are the answer - Authors' reply.

Soucy JR, Langford BJ, So M, Raybardhan S, MacFadden D, Daneman N, Bertagnolio S. Lancet Microbe, 2023;25:S2666-5247(23)00098-8.

  • Antibiotic treatment durations for pyogenic liver abscesses: A systematic review

 Curran J, Mulhall C, Pinto R et al. JAMMI. 2023

  • Identifying Outpatient Antibiotic Prescribers and Recipients in a primary care Spinal Cord Injury Cohort

 Senthinathan A, Penner M, Tu K, Morris A, et al. Archives of Physical Medicine and Rehabilitation. 2023:104(3): e32-e33.

  • Investigate Primary Care Antibiotic Prescribing in a Spinal Injury (SCI) cohort using an EMR Database

Senthinathan A, Tu K, Penner M, Craven BC, Morris A, et al. Archives of Physical Medicine and Rehabilitation. 2023: 104(3):e36.

  • Vancomycin Therapeutic Drug Monitoring: A Cross-Sectional Survey of Canadian Hospitals

Jorgensen S, McIntyre M, Curran J, So MCanadian Journal of Hospital Pharmacy, 2023;Early access

  • A national survey of antimicrobial stewardship content in Canadian entry-to-practice pharmacy programs

Sauve J, Dresser L, Rocchi M, & So MAntimicrobial Stewardship & Healthcare Epidemiology, 2023;3(1): E86.

  • Antimicrobial resistance in patients with COVID-19: a systematic review and meta-analysis

Langford BJ, So M, Simeonova M et al. Lancet Microbe, 2023;4(3):e179–91.

  • Fidaxomicin to prevent recurrent Clostridioides difficile: what will it cost in the USA and Canada?

Patel D, Senecal J, Spellberg B, Morris AM, et al. JAC-Antimicrobial Resistance, 2023; 5(1): dlac138.

  • COVID-19 Vaccination is Associated with Reduced Outpatient Antibiotic Prescribing In Older Adults with Confirmed SARS-CoV-2: A Population Wide Cohort Study

MacFadden DR, Maxwell C, Bowdish D, Bronskill S, Brooks J, Brown K, Burrows LL, Clarke A, Langford B, Leung E, Leung V, Manuel D, McGeer A, Nott C, Mishra S, Morris AM, Raybardhan S, Sapin M, Schwartz KL, So M et al. Clin Infect Dis, 2023: ciad190.

  • Validation of the Antifungal National Antimicrobial Prescribing Survey (AF-NAPS) quality assessment tool

Khanina A, Douglas AP, Yeoh DK, So M    J Antimicrob Chemother, 2023:dkad085.

  • Going local: Evaluating guideline adherence and appropriateness of antibiotic prescribing in patients with febrile neutropenia at an academic teaching hospital.

Liu R, Gitman M, Morris A, & So M. Antimicrobial Stewardship & Healthcare Epidemiology, 2023; 3(1): E3.


Impact of a Multifaceted Approach to Audit-and-Feedback Antimicrobial Stewardship Intervention in Acute Leukemia Patients Using Measures of Appropriateness

So M, Alahmadi G et alIDWeek, 2023.

Increasing Perioperative Cefazolin Utilization for Surgical Site Infection Prophylaxis in β-Lactam Allergic Patients at a hospital network with 59,862 patients.

Esmail T, McIntyre M, Wong DT, et al. Association of Medical Microbiology and Infectious Disease Canada, 2023.

The Design and Implementation of a Patient and Procedure-Specific Surgical Antimicrobial Prophylaxis Computerized Decision Support Tool. An OPTIMIzing Surgical PROphylaxis (OPTIMIS PRO) project.

McIntyre M, Vaisman AAssociation of Medical Microbiology and Infectious Disease Canada, 2023.

Surgical Antimicrobial Prophylaxis (SAP) Decision-Making and Disagreement in the Operating Room: A Thematic Analysis

Ghataura J, Jeffs L, McIntyre M. Canadian Society of Hospital Pharmacists, 2023.

International Forum on Quality & Safety in Healthcare, 2023.


  • Canada has an opportunity to address antimicrobial resistance through COVID-19 recovery spending.

Somanader DS, Brunskill I, Perrin M, Barkema HW, Hillier S, Hindmarch S, Weese JS, Wright GD, Morris AMLancet Reg Health Am, 2022;16:100393.

  • Antibiotic resistance associated with the COVID-19 pandemic: a systematic review and meta-analysis

Langford BJ, Soucy JR, Leung V, So M et al. Clin Microbiol Infect. 2022; S1198-743X(22)00610-3.

  • Low-dose trimethoprim-sulfamethoxazole for the treatment of Pneumocystis jirovecii pneumonia (LOW-TMP): protocol for a phase III randomised, placebo-controlled, dose-comparison trial.

Sohani ZN, Butler-Laporte G, Aw A, Belga S, Benedetti A, Carignan A, Cheng MP, Coburn B, Costiniuk CT, Ezer N, Gregson D, Johnson A, Khwaja K, Lawandi A, Leung V, Lother S, MacFadden D, McGuinty M, Parkes L, Qureshi S, Roy V, Rush B, Schwartz I, So M, et al. BMJ Open, 2022;12(7):e053039.

  • Antimicrobial stewardship in solid organ transplantation—A call for action!

Forrest GN, So M, Hand J, Pouch S, Husain S. Transpl Infect Dis, 2022;24:e13938.

  • Use of Novel Strategies to Develop Guidelines for Management of Pyogenic Osteomyelitis in Adults: A WikiGuidelines Group Consensus Statement.

Spellberg B, Aggrey G, Brennan MB, Footer B, Forrest G, Hamilton F, Minejima E, Moore J, Ahn J, Angarone M, Centor RM, Cherabuddi K, Curran J, Davar K, Davis J, Dong MQ, Ghanem B, Hutcheon D, Jent P, Kang M, Lee R, McDonald EG, Morris AM, Reece R, Schwartz IS, So M, et al. JAMA Netw Open, 2022;5(5):e2211321. 

  • Auditing tools for antimicrobial prescribing in solid organ transplant recipients: The why, the how, and an assessment of current options

So M, Nakamachi Y, Thursky K. Transpl Infect Dis, 2022;24:13905.

  • Knowledge, perspectives and health outcome expectations of antibiotic therapy in hospitalized patients. 

Jorgoni L, Camardo E, Jeffs L, Nakamachi Y, Somanader D, Bell CM, Morris AMInfect Prev Pract. 2022;4(4):100245.

  • Staphylococcus aureus bacteremia mortality across country income groups: A secondary analysis of a systematic review.

Bai AD, Lo CK, Komorowski AS, Suresh M, Guo K, Garg A, Tandon P, Senecal J, Corpo OD, Stefanova I, Fogarty C, Butler-Laporte G, McDonald EG, Cheng MP, Morris AM et al. Int J Infect Dis, 2022:S1201-9712(22)00357-5 [Epub] 

  • Allocated but not treated: the silent 16.

Lee TC, Morris AM et al. Lancet, 2022;399(10337):1775. 

  • What Is the Optimal Follow-up Length for Mortality in Staphylococcus aureus Bacteremia? Observations From a Systematic Review of Attributable Mortality.

Bai AD, Lo CKL, Komorowski AS, Suresh M, Guo K, Garg A, Tandon P, Senecal J, Del Corpo O, Stefanova I, Fogarty C, Butler-Laporte G, McDonald EG, Cheng MP, Morris AM, et al. Open Forum Infect Dis, 2022;9(5):ofac096. 

  • Reporting behaviors and perceptions toward the National Healthcare Safety Network antimicrobial use (AU) and antimicrobial resistance (AR) modules. 

Werth BJ, Dilworth TJ, Escobar ZK, Gross AE, Suda KJ, Morris AM et al. Infect Control Hosp Epidemiol, 2022:1-7 [Epub]. 

  • A Time Series Analysis Evaluating Antibiotic Prescription Rates in Long-Term Care during the COVID-19 Pandemic in Alberta and Ontario, Canada.

Haverkate MR, Macfadden DR, Daneman N, Leal J, Otterstatter M, Mahdavi R, D'Souza AG, Rennert-May E, Silverman M, Schwartz KL, Morris AM, Saatchi A, Patrick DM, Marra F. Antibiotics (Basel). 2022;11(8):1001.

  • Reliability of nonlocalizing signs and symptoms as indicators of the presence of infection in nursing-home residents.

Rowe TA, Jump RLP, Andersen BM, Banach DB, Bryant KA, Doernberg SB, Loeb M, Morgan DJ, Morris AM, et al. Infect Control Hosp Epidemiol, 2022;43(4):417-426. 

  • Challenges of Antimicrobial Resistance and Stewardship in Solid Organ Transplant Patients.

So M, Walti L. Infect Dis Rep., 2022; 24: 63–75.

  • Staphylococcus aureus bacteraemia mortality: a systematic review and meta-analysis.

Bai AD, Lo CKL, Komorowski AS, Suresh M, Guo K, Garg A, Tandon P, Senecal J, Del Corpo O, Stefanova I, Fogarty C, Butler-Laporte G, McDonald EG, Cheng MP, Morris AM, Loeb M, Lee TC. Clin Microbiol Infect. 2022;28(8):1076-1084.

  • Bring it on: Top five antimicrobial stewardship challenges in transplant infectious diseases and practical strategies to address them

So M, Tsai H, Swaminathan N, & Bartash R. Antimicrob Steward Healthc Epidemiol, 2022; 2(1): E72.

  • The feasibility and generalizability of assessing the appropriateness of antimicrobial prescribing in hospitals: a review of the Australian National Antimicrobial Prescribing Survey 

James R, Nakamachi Y, Morris AM, So M, et al. JAC-Antimicrobial Resistance, 2022;4(1): dlac012.

  • Evaluation of different antimicrobial stewardship models at a rehabilitation hospital: An interrupted time series (ITS) study. 

Curran J, Leis J, Robinson L, et al. Antimicrob Steward Healthc Epidemiol, 2022; 2(1): E45.

  • Global resilience and new strategies needed for antimicrobial stewardship during the COVID-19 pandemic and beyond retrospective, controlled study. 

Goff D, Gauthier TP, Langford BJ, Prusakov P, Chukwuema MU, Nwomeh BC, Yunis KA, Saad T, van den Bergh D, Villegas MV, Martinez N, Morris AM, et al.  Journal of the American College of Pharmacy, 2022.[Epub]

  • How generalizable are randomized controlled trials (RCTs) in Staphylococcus aureus bacteremia? A description of the mortality gap between RCTs and observational studies.

Bai AD, Lo CKL, Komorowski AS, Suresh M, Guo K, Garg A, Tandon P, Senecal J, Del Corpo O, Stefanova I, Fogarty C, Butler-Laporte G, McDonald EG, Cheng MP, Morris AM, et al, Clin Infect Dis, 2022: ciac177.

  • The Harms of Postoperative Antibiotic Prophylaxis: A Teachable Moment.

Halani S, McIntyre M, Vaisman A. JAMA Intern Med, 2022.[Epub]

  • Patterns of Antimicrobial Use in an Outpatient Hemodialysis Unit.

Sivarajahkumar S, So M, Morris AM, Lok C, Bell CM, Battistella M. Can J Hosp Pharm. 2022;75(1):15-20.

  • Outpatient Therapies for COVID-19: How Do We Choose?

Lee TC, Morris AM, Grover SA, Murthy S, McDonald EG. Open Forum Infect Dis., 2022;9(3):ofac008

  • Antibiotic prescribing patterns among patients admitted to an academic teaching hospital for COVID-19 during the first wave of the pandemic in Toronto: A retrospective, controlled study. 

So M, Morris A, Walker AM. JAMMI, 2022; 7(1): 14-22.


Use of Nudging Strategies to Develop a Clinical Microbiology Antimicrobial Stewardship Framework.

McIntyre M, Langford BJ, Leung E et al. European Congress of Clinical Microbiology and Infectious Diseases 2022.

A national survey of antimicrobial stewardship content in Canadian Undergraduate Pharmacy Programs.

Sauve J, Dresser L, Rocchi M, So M. Canadian Society of Hospital Pharmacists 2022

Building Consensus on Antimicrobial Stewardship Nudges. 

McIntyre M, Langford BJ, Leung E et al. Association of Medical Microbiology and Infectious Diseases Canada 2022.

Increasing Perioperative Cefazolin Utilization for Surgical Site Infection Prophylaxis in β-Lactam Allergic Patients: An interrupted time-series study.

Vaisman A, McIntyre M, Wong DT et al. Canadian Anesthesiologists' Society 2022

Delphi panel on Antimicrobial Stewardship and Management of Clinical Syndromes in Thoracic Organ Transplants and Mechanical Circulatory Device Recipients

Luong M, Silveira FP, Morrissey O, Danziger-Isakov L, Verschuuren E, Wolfe CR, Hadjiliadis D, Chambers D, Patel JK, Dellgren G, So M, Verleden GM, Blumberg EA, Vos R, Perch M, Holm AM, Müller N, Chaparro C, Husain S. International Society for Heart and Lung Transplantation 2022


  • ​Predictors and microbiology of respiratory and bloodstream bacterial infection in patients with COVID-19: living rapid review update and meta-regression. 

Langford BJ, So M et al. Clin Microbiol Infect, 2021;S1198-743X(21)00636-4.

  • Baricitinib: impact on COVID-19 coagulopathy?

 Jorgensen SCJ, Burry L, Tse CY, Dresser LD. Clin Infect Dis, 2021 Dec 6;73(11):e3978-e3979.

  • Characterizing the inclusion of pregnant and breastfeeding people in infectious diseases randomized controlled trials: a targeted literature review.

  • Estimating daily antibiotic harms: an umbrella review with individual study meta-analysis.

  • Community Pharmacist Prescribing of Antimicrobials: A Systematic Review from an Antimicrobial Stewardship Perspective.

 Leung V, Langford B, McIntyre M, Khalid F, Wu JCH, et al.  Can Pharm J (Ott). 2021 Apr 8;154(3):179-192.

2021 CJP Best Paper 

  • The Impact of COVID-19 on Outpatient Antibiotic Prescriptions in Ontario, Canada; An Interrupted Time Series Analysis. 

Kitano T, Brown KA, Daneman N, MacFadden DR, Langford BJ, Leung V, So M, et al. Open Forum Infect Dis. 2021;8(11): ofab533.


Comparing All-Cause to Procedure-Related Mortality in Cardiac Implantable Electronic Device (CIED) Lead Removals: A Systematic Review.

Herman J, Somanader D, Ishaq L, Abdelaal A, Mehra V, Ramendra E, Morris AM. American Heart Association, 2021.

Nudging in MicroBiology Laboratory Evaluation (NIMBLE): Developing a Framework for Microbiology Nudging Interventions.

Matukas L, Langford, BJ, Leung E, McIntyre M. Nudges in Healthcare Symposium, 2021.

Success and Complication Rates in Cardiac Implantable Electronic Device (CIED) Laser Lead Extractions: A Systematic Review

Mehra V, Herman JE, Somanader D, Ishaq L, Abdelaal A, Ramendra R, Morris AM, American Heart Association, 2021.


  • Presence of urinary symptoms in bacteremic urinary tract infection: a retrospective cohort study of Escherichia coli bacteremia.

Bai AD, Bonares MJ, Thrall S, Bell C, Morris AM. BMC Infect Dis, 2020; 20: 781

  • Variation in antibiotic use across intensive care units (ICU): A population-based cohort study in Ontario, Canada

Lee EY, Detsky ME, Ma J, Bell CM, Morris AM. Infect Control Hosp Epidemiol, 2020;41(9):1035-1041.

  • Bacterial Co-Infection and Secondary Infection in Patients with COVID-19: A Living Rapid Review and Meta-Analysis.

Langford BJ, So M, Raybardhan S, et al. Clin Microbiol Infect., 2020;26(12):1622-1629.

  • Should Therapeutic Monitoring of Vancomycin Based on Area under the Curve, Become Standard Practice for Patients with Confirmed or Suspected Methicillin-Resistant Staphylococcus aureus Infection?

Claeys KC, Brade KD, Heil EL, Jorgensen SCJ. Can J Hosp Pharm, 2020; 73(3)

  • Governing Antimicrobial Resistance: A Narrative Review of Global Governance Mechanisms. 

Ruckert A, Fafard P, Hindmarch S, Morris AMJ Public Health Policy, 2020;41(4):515-528.

  • Evaluating the Effect of Nurse Initiated Discussion of Infection Management during ICU Bedside Rounds.

 Dresser L, McIntyre M, Jorgoni L, Stephenson A, Nelson S, Jorgensen S, Bell CM, Morris AM. BMJ Open Qual, 2020 Nov;9(4):e001037

  • Defining appropriate antibiotic prescribing in primary care: a modified Delphi panel approach.

 Hui-Chih J, Langford B, Ha R, Garber G, Daneman N, Johnstone J, McIsaac W, Sharpe S, Tu K, Schwartz KL. JAMMI, 2020; 5(2): 61-69.

  • Bacterial Co-Infection and Secondary Infection in Patients with COVID-19: A Living Rapid Review and Meta-Analysis.

Langford B, So M, Raybardhan S, et al. Clin Microbiol Infect, 2020 Dec;26(12):1622-1629.

  • Vancomycin AUC-guided therapeutic drug monitoring to reduce nephrotoxicity: are we overlooking a simpler solution? Comment on: Oda K, Jono H, Nosaka K, Saito H. Reduced nephrotoxicity in vancomycin therapeutic drug monitoring guided by area under the concentration-time curve against trough 15-20 µg/mL concentration.

Jorgensen SCJ, Stewart JS, Dalton B. Int J Antimicrob Agents, 2020 Nov;56(5):106150.

  •  A Canadian Perspective on the Revised 2020 ASHP/IDSA/PIDS/SIDP Guidelines for Vancomycin AUC-Based Therapeutic Drug Monitoring for Serious MRSA Infections.

Stewart JS, Jorgensen SCJ, Dresser LD, et al. JAMMI, 2020; 6(1): 3-9.

  • Remdesivir: A review of pharmacology, pre-clinical data and clinical experience for COVID-19. 

Jorgensen SCJ, Kebriaei R, Dresser LD. Pharmacotherapy, 2020 Jul;40(7):659-671. Epub 2020 Jun 28.

  • Development and evaluation of a primary care antimicrobial stewardship program (PC-ASP) in Toronto, Canada.

McIsaac W, Morris A et al. JAMMI, 2020; 6(1): 32-48.

  • Baricitinib:  review of pharmacology, safety and emerging clinical experience for COVID-19.

Jorgensen SCJ, Tse CLY, Burry L, Dresser LD.  Published at Pharmacotherapy, 2020 Aug;40(8):843-856.

  • Daptomycin Plus β-Lactam Combination Therapy for Methicillin-resistant Staphylococcus aureus Bloodstream Infections: A Retrospective, Comparative Cohort Study-

Jorgensen SCJ, Zasowski EJ, Trinh TD, eta l. Clin Infect Dis, 2020 Jun 24;71(1):1-10. 

  •  Antiviral Therapy during the Coronavirus Disease (COVID-19) Pandemic: Is It Appropriate to Treat Patients in the Absence of Significant Evidence?

Dalton BR, Dresser LD, Thirion DJG. Can J Hosp Pharm, 2020; 73(2)

  • Evaluating and Prioritizing Antimicrobial Stewardship Programs for Nursing Homes: A Modified Delphi Panel.

Kruger SZ, Bronskill SE, Jeffs L, Steinberg M, Morris AM, Bell CM.  Infect Control Hosp Epidemiol, 2020 Sep;41(9):1028-1034.

  • Counterpoint: Vancomycin AUC-based therapeutic drug monitoring should NOT become standard for patients with confirmed or suspected methicillin-resistant Staphylococcal aureus infections.

Jorgensen SCJ, Dresser LD, Dalton B. Can J Hosp Pharm, 2020; 73(3): 232.

  • Finding the relevance of antimicrobial stewardship for cystic fibrosis.

 Cogen JD, Kahl BC, Maples H, McColley, Roberts JA, Winthrop KL, Morris AM, et al. Journal of Cystic Fibrosis, 2020;19(4): 511-520.

  • Unnecessary antibiotic prescribing in a Canadian primary care setting: a descriptive analysis using routinely collected electronic medical record data. 

Schwartz KL, Langford BJ, Daneman N, Chen B, Brown KA, McIsaac W, Tu K, Candido E et al. CMAJ Open, 2020; 8(2): E360-E369

  • A behavioural approach to specifying interventions: what insights can be gained for the reporting and implementation of interventions to reduce antibiotic use in hospitals?

Duncan EM, Charani E, Clarkson JE, Francis JJ,  Gillies K,  Grimshaw JM, Kern WV, Lorencatto F, Marwick CA, McEwen J, Mohler R, Morris AM, et al. J Antimicrob Chemother, 2020 May 1;75(5):1338-1346

  • Bacterial Co-Infection and Secondary Infection in Patients with COVID-19: A Living Rapid Review and Meta-Analysis.

Langford B, So M, Raybardhan S, Leung V, Westwood D, MacFadden D, Soucy J, Daneman N. Clin Microbiol Infect, 2020 Dec;26(12):1622-1629.


Declining rates of AOM in British Columbia: the impact of pneumococcal conjugate vaccines
on disease burden and antibiotic use.

Saatchi A, Khatri Vadlamudi N, Patrick DM, Morris AM, Silverman M, Sadarangani M, Marra F. AMMI Canada, 2020.

bottom of page